209 related articles for article (PubMed ID: 8803513)
1. Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy.
Küpfer A; Aeschlimann C; Cerny T
Eur J Clin Pharmacol; 1996; 50(4):249-52. PubMed ID: 8803513
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of (mono)amine oxidase activity and prevention of ifosfamide encephalopathy by methylene blue.
Aeschlimann C; Cerny T; Küpfer A
Drug Metab Dispos; 1996 Dec; 24(12):1336-9. PubMed ID: 8971139
[TBL] [Abstract][Full Text] [Related]
3. [Successful treatment with methylene blue of ifosfamide-induced central nervous system effects].
Demandt M; Wandt H
Dtsch Med Wochenschr; 1996 Apr; 121(17):575. PubMed ID: 8620831
[No Abstract] [Full Text] [Related]
4. Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue.
Küpfer A; Aeschlimann C; Wermuth B; Cerny T
Lancet; 1994 Mar; 343(8900):763-4. PubMed ID: 7510815
[TBL] [Abstract][Full Text] [Related]
5. [Methylene blue in ifosfamide-induced encephalopathy].
Koschuth A; Späth-Schwalbe PE; Possinger K
Dtsch Med Wochenschr; 1996 Sep; 121(39):1210. PubMed ID: 8925751
[No Abstract] [Full Text] [Related]
6. Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature.
Pelgrims J; De Vos F; Van den Brande J; Schrijvers D; Prové A; Vermorken JB
Br J Cancer; 2000 Jan; 82(2):291-4. PubMed ID: 10646879
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide encephalopathy and use of methylene blue. A case report of different sequential neurotoxicity.
Giovanis P; Garna A; Marcante M; Nardi K; Giusto M
Tumori; 2009; 95(4):545-6. PubMed ID: 19856674
[TBL] [Abstract][Full Text] [Related]
8. The Use of Continuous Veno-Venous Hemodiafiltration in the Management of Ifosfamide-induced Encephalopathy: A Case Report.
Yeo KK; HaDuong JH
J Pediatr Hematol Oncol; 2016 Aug; 38(6):489-90. PubMed ID: 26907647
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of ifosfamide induced encephalopathy with methylene-blue].
Ferrero JM; Eftekari P; Largillier R; Dreyfus G; Namer M
Bull Cancer; 1995 Jul; 82(7):598-9. PubMed ID: 7549123
[TBL] [Abstract][Full Text] [Related]
10. Methylene blue and ifosfamide-induced encephalopathy: Myth or reality?
Abahssain H; Moukafih B; Essangri H; Mrabti H; Meddah B; Guessous F; Fadhil FZ; Souadka A; Errihani H
J Oncol Pharm Pract; 2021 Jan; 27(1):143-149. PubMed ID: 33153383
[TBL] [Abstract][Full Text] [Related]
11. Ifosfamide-related encephalopathy in elderly patients : report of five cases and review of the literature.
Brunello A; Basso U; Rossi E; Stefani M; Ghiotto C; Marino D; Crivellari G; Monfardini S
Drugs Aging; 2007; 24(11):967-73. PubMed ID: 17953463
[TBL] [Abstract][Full Text] [Related]
12. Methylene blue for the treatment and prophylaxis of ifosfamide-induced encephalopathy.
Turner AR; Duong CD; Good DJ
Clin Oncol (R Coll Radiol); 2003 Oct; 15(7):435-9. PubMed ID: 14570094
[TBL] [Abstract][Full Text] [Related]
13. Hydration, methylene blue, and thiamine as a prevention regimen for ifosfamide-induced encephalopathy.
Gharaibeh EZ; Telfah M; Powers BC; Salacz ME
J Oncol Pharm Pract; 2019 Oct; 25(7):1784-1786. PubMed ID: 30348070
[TBL] [Abstract][Full Text] [Related]
14. [Ifosfamide induced encephalopathy: 15 observations].
Dufour C; Grill J; Sabouraud P; Behar C; Munzer M; Motte J; Oberlin O; Paci A; Hartmann O
Arch Pediatr; 2006 Feb; 13(2):140-5. PubMed ID: 16364615
[TBL] [Abstract][Full Text] [Related]
15. Possible role of CYP2B6 genetic polymorphisms in ifosfamide-induced encephalopathy: report of three cases.
Duflot T; Marie-Cardine A; Verstuyft C; Filhon B; Pereira T; Massy-Guillemant N; Joannidès R; Bellien J; Lamoureux F
Fundam Clin Pharmacol; 2018 Jun; 32(3):337-342. PubMed ID: 29319893
[TBL] [Abstract][Full Text] [Related]
16. Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature.
Sweiss KI; Beri R; Shord SS
Drug Saf; 2008; 31(11):989-96. PubMed ID: 18840018
[TBL] [Abstract][Full Text] [Related]
17. Ifosfamide induced encephalopathy in a child with osteosarcoma.
Sarbay H; Demir ÜF; Yılmaz G; Atay AA; Malbora B
J Oncol Pharm Pract; 2021 Jul; 27(5):1302-1306. PubMed ID: 33023384
[TBL] [Abstract][Full Text] [Related]
18. Serotonin Syndrome Complicating Treatment of Ifosfamide Neurotoxicity With Methylene Blue.
Snyder M; Gangadhara S; Brohl AS; Ludlow S; Nanjappa S
Cancer Control; 2017; 24(5):1073274817729070. PubMed ID: 28975823
[TBL] [Abstract][Full Text] [Related]
19. [Ifosfamide-related encephalopathy. Report of two cases].
Dourthe LM; Coutant G; Desrame J; Merrer J; Daly JP
Rev Med Interne; 1999 Mar; 20(3):264-6. PubMed ID: 10216884
[TBL] [Abstract][Full Text] [Related]
20. [Treatment and prevention of iphosphamide-induced encephalopathy].
Sunela K; Bärlund M
Duodecim; 2016; 132(4):314-7. PubMed ID: 27017785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
